Company intelligence / Profile preview

Zhongjintai Venture Capital

Shenzhen, Guangdong, China

Ownership: Private
Development stage: Other

Overview

Zhongjintai Venture Capital is a Shenzhen-based venture capital firm rather than an operating biotech, pharma, or healthcare company. Publicly accessible references identify it as Zhongjintai Venture Capital (Shenzhen) Co., Ltd., established in 2016 and active in business services and investment activities in China. Available information indicates the firm is active and has been referenced in third-party filings as a venture capital firm in Shenzhen, with Sheng "Dorothy" Liu cited as CEO in 2022. I did not find reliable evidence that Zhongjintai itself develops therapeutics, diagnostics, or healthcare products, so it should not be categorized as a life sciences operating company.

Industry: Investors

Beyond the preview

Go deeper on Zhongjintai Venture Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhongjintai Venture Capital.

Explore the full profile